ALERT-FDA Drug Shortage-Cefazolin Injection-Antibiotic

The FDA is reporting a drug shortage of Cefazolin Injection
Currently in Shortage
30 November 2018
Therapeutic Categories: Anti-Infective

Shortages due to increased demand

Drug Companies with shortages,

• Apotex Corp.
• Braun Medical Inc.
• Hospira Inc.
• Sagent Pharmaceuticals
• West-Ward Pharmaceuticals
• WG Critical Care

CEFAZOLIN-also known as the brand names: Kefzol and Ancef
Cefazolin is an antibiotic used to treat a wide variety of bacterial infections. It may also be used before and during certain surgeries to help prevent infection. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. (RxList, 2018)

Cefazolin is available under the following different brand names: Kefzol and Ancef

Details on drug shortage doses please see FDA website,

https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?utm_campaign=12-3-2018%20Drug%20Shortages&utm_medium=email&utm_source=Eloqua&AI=Cefazolin+Injection&st=c&tab=tabs-4&panels=0&elqTrackId=e46e939de1b141d3944fd7455f60beb0&elq=95eceae67a5a4409afe73015724b321f&elqaid=6147&elqat=1&elqCampaignId=4984#

Resources
Cefazolin-RxList (2018) https://www.rxlist.com/consumer_cefazolin_kefzol_ancef/drugs-condition.htm